methionine sulfoximine has been researched along with Cancer of Stomach in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, J; Guo, Q; Ji, H; Li, T; Liu, L; Tan, J; Zhang, Y | 1 |
Furukawa, T; Ishibiki, K; Kitajima, M; Kubota, T; Kuo, TH; Saikawa, Y; Tanino, H; Watanabe, M | 1 |
Hong, YS; Kang, JH; Kim, DJ; Kim, HK; Lee, KS; Moon, HS; Park, JG | 1 |
Cai, RM; Ding, L; Jin, XQ; Jin, YZ; Lu, WQ; Shen, ZF; Xu, JF; Xu, LM; Yang, JK | 1 |
Barranco, SC; Beasley, EG; Liu, NH; MacLean, KK; Schellenberg, K; Shaeffer, J; Townsend, CM; Weintraub, B | 1 |
5 other study(ies) available for methionine sulfoximine and Cancer of Stomach
Article | Year |
---|---|
NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells.
Topics: Acetylcysteine; Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Azo Compounds; bcl-2-Associated X Protein; Caspase 9; Cell Proliferation; Glutathione; Glutathione Peroxidase; Humans; Malondialdehyde; Membrane Potential, Mitochondrial; Methionine Sulfoximine; Mitochondria; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Prodrugs; Proto-Oncogene Proteins c-bcl-2; Saponins; Stomach Neoplasms; Superoxide Dismutase | 2014 |
Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.
Topics: Animals; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; Humans; Male; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Nude; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cisplatin; Female; Glutathione; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Stomach Neoplasms; Tumor Cells, Cultured | 1992 |
Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Hypoxia; Cisplatin; Drug Synergism; Fluorouracil; Glutathione; Humans; Leukemia, Erythroblastic, Acute; Methionine Sulfoximine; Misonidazole; Stomach Neoplasms; Tumor Cells, Cultured | 1992 |
Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Drug Screening Assays, Antitumor; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Stomach Neoplasms; Time Factors; Tumor Cells, Cultured | 1990 |